ATC Group: N02CD05 Eptinezumab

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02CD05 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02C Antimigraine preparations
4 N02CD Calcitonin gene-related peptide (CGRP) antagonists
5 N02CD05

Related product monographs

Document Type Information Source  
 VYEPTI Concentrate for solution for infusion MPI, EU: SmPC European Medicines Agency (EU)
 VYEPTI Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Estonia (EE)

France (FR)

Israel (IL)

Lithuania (LT)

Poland (PL)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.